Integrative Genomics and Medicine

Lead Research Organisation: MRC Clinical Sciences Centre

Abstract

The classic forward genetics approach aims to identify discrete variations in the DNA (i.e., genes) that can cause very complex diseases, such as hypertension or diabetes. To date, this reductionist approach, although successful in the early days of gene screening for simple and rare diseases, failed to recognize the true complexity underlying common disorders. Because the majority of genes and proteins function together with other genes and proteins in a combinatorial way, the biological process underlying complex diseases is better characterized as complex interactions of interconnected components (i.e., genes, proteins). In view of this complexity, new types of approaches are required, and now information about thousands of genes, proteins and their regulators is available for understanding these complex systems. These extensive data can be processed to reconstruct informative sets of interacting genes, also called gene networks, that can be relevant to specific diseases. Our research is based on the identification and characterization of complex genetic networks to improve our understanding of the physiological mechanisms linked to common disorders, with the aim of discovering new and more effective therapeutic treatments.

Technical Summary

My research focuses on the development of new, efficient and multidisciplinary approaches for integrated genetic, genomic and phenotypic analyses, with specific applications to cardiovascular and metabolic diseases. The program of research focuses on: 1) modelling gene regulatory networks across multiple tissues; 2) integrated multi-phenotype and linkage analyses of cardiovascular and metabolic traits, and 3) extension of these approaches to incorporate human Genome-Wide Association Studies (GWAS) data, expression QTL (eQTL) and next-generation sequencing data. In particular, the methodologies and tools will be employed to reconstruct pathways and network models using reverse engineering approaches to predict the consequences of genetic and genomic variants on clinically relevant whole-body phenotypes. The generality of this modelling approach makes it adaptable to several model systems (rats, humans) with broad application to multiple phenotype analyses, including transcriptional and epigenetic profiles, or genetically complex cardiovascular traits. Through the implementation of powerful analytical strategies to highly dimensional datasets, we will enable integrative genomics approaches to uncover complex regulatory mechanisms underlying cardiovascular and metabolic traits.||Specific Objectives:||To build transcriptional networks using graphical models and integrate these with phenotypic, epigenetic, transcriptomic, proteomic and metabonomic data using high-throughput next generation sequencing data in rats and humans.|To extend predictive Bayesian models for multi-phenotype mapping in humans, integrating GWAS and eQTL data.|To evaluate the relevance of disease regulatory networks across multiple species, integrating relevant human data (gene expression, GWAS) to discriminate between alternative models of regulatory control of patho-physiological phenotypes.

Publications


10 25 50
Aitman TJ (2010) Genetic mapping and positional cloning. in Methods in molecular biology (Clifton, N.J.)
Behmoaras J (2015) Macrophage epoxygenase determines a profibrotic transcriptome signature. in Journal of immunology (Baltimore, Md. : 1950)
Beltrami C (2017) Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis. in Molecular therapy : the journal of the American Society of Gene Therapy
 
Description Clinical Science Centre Computational Biology Workshop
Geographic Reach Local/Municipal/Regional 
Policy Influence Type Influenced training of practitioners or researchers
 
Description Synthetic & Systems Biology
Geographic Reach Asia 
Policy Influence Type Influenced training of practitioners or researchers
 
Description BHF PhD Studentship Grant
Amount £92,050 (GBP)
Organisation British Heart Foundation (BHF) 
Sector Charity/Non Profit
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 10/2011 
End 10/2014
 
Description BHF Program Grant
Amount £742,908 (GBP)
Organisation British Heart Foundation (BHF) 
Sector Charity/Non Profit
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 08/2012 
End 08/2015
 
Description BHF Project Grant
Amount £191,000 (GBP)
Organisation British Heart Foundation (BHF) 
Sector Charity/Non Profit
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 09/2010 
End 09/2012
 
Description BHF Project Grant
Amount £180,000 (GBP)
Organisation British Heart Foundation (BHF) 
Sector Charity/Non Profit
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 10/2012 
End 10/2015
 
Description BHF Project Grant
Amount £124,265 (GBP)
Organisation British Heart Foundation (BHF) 
Sector Charity/Non Profit
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 07/2011 
End 07/2013
 
Description BRC Project Grant/BRC
Amount £150,000 (GBP)
Organisation NIHR Imperial Biomedical Research Centre 
Sector Public
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 08/2010 
End 08/2012
 
Description British council Travel Award
Amount £2,800 (GBP)
Organisation British Council 
Sector Charity/Non Profit
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 08/2009 
End 08/2010
 
Description European Union's 7th Framework Programme (FP7)
Amount £749,443 (GBP)
Organisation Community Research and Development Information Service (CORDIS) 
Department Seventh Framework Programme (FP7)
Sector Public
Country European Union (EU)
Start  
 
Description European Union's Seventh Framework Programme/Max Delbrueck Centrum Fuer Molekulare Medizin
Amount £209,000 (GBP)
Organisation Helmholtz Association of German Research Centres 
Department The Max Delbrück Center for Molecular Medicine (MDC)
Sector Academic/University
Country Germany, Federal Republic of
Start 08/2009 
End 08/2013
 
Description Imperial College Networks of Excellence Award
Amount £50,580 (GBP)
Organisation Imperial College London (ICL) 
Sector Academic/University
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start  
 
Description MRC Research Grant
Amount £209,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start  
 
Description MRC Tenure
Amount £805,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 04/2011 
End 03/2016
 
Description NIHR Biomedical Research Centre/Imperial Innovations
Amount £39,500 (GBP)
Organisation National Institute for Health Research (NIHR) 
Department NIHR Barts Cardiovascular Biomedical Research Unit
Sector Public
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 07/2012 
End 04/2013
 
Description The Academic Health Science Centre (AHSC)
Amount £529,051 (GBP)
Organisation University College London Hospitals Charity (UCLH) 
Department National Institute for Health Research (NIHR)
Sector Public
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 09/2011 
End 10/2014
 
Description UCB Pharma
Amount £395,963 (GBP)
Organisation UCB Pharma 
Sector Private
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start 04/2012 
End 04/2014
 
Description Wellcome Trust Project Grant
Amount £105,437 (GBP)
Organisation The Wellcome Trust Ltd 
Sector Charity/Non Profit
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start  
 
Description Wellcome Trust Project Grant/Welcome Trust
Amount £240,273 (GBP)
Organisation The Wellcome Trust Ltd 
Sector Charity/Non Profit
Country United Kingdom of Great Britain & Northern Ireland (UK)
Start  
 
Title Bayesian Variable Selection method 
Description C++: objected-oriented algorithm for Bayesian stochastic search model exploration. Software to link genetic variants to gene expression levels. 
Type Of Material Technology assay or reagent 
Year Produced 2011 
Provided To Others? Yes  
Impact Publication: Bionformatics (Oxford, England) 27,4, 587-8. 
 
Title Clustering algortihm (C3D) 
Description New algorithm (C3D) to identify co-expression networks and clusters simultaneously in multiple conditions using non-parametric higher-order generalized singular value decomposition. 
Type Of Material Technology assay or reagent 
Year Produced 2014 
Provided To Others? Yes  
Impact Publication: PLoS Genetics 2014, 10(1):e1004006 Identification of heat shock protein genes co-regulated with cardiomiopathy genes in rat and human heart. 
URL http://www.csc.mrc.ac.uk/Research/Groups/GMC/IntegrativeGenomicsMedicine/
 
Description BHF Program Grant 
Organisation Faculty of Engineering
Department Department of Bioengineering
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution co applicants on Grant title "Blood flow affects the spatial oranizatoin of (vulnerable) plaques: new ways to modify TCFA formation"
Collaborator Contribution Co-applicant on the GrantCo-applicant on grantCo-applicant on Grant
Impact Project due to start January 2012
Start Year 2011
 
Description BHF Program Grant 
Organisation Imperial College of Science Technology and Medicine (ICSTM)
Department Department of Cell and Molecular Biology
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution co applicants on Grant title "Blood flow affects the spatial oranizatoin of (vulnerable) plaques: new ways to modify TCFA formation"
Collaborator Contribution Co-applicant on the GrantCo-applicant on grantCo-applicant on Grant
Impact Project due to start January 2012
Start Year 2011
 
Description BHF Program Grant 
Organisation National Institutes of Health (NIH)
Department National Heart, Lung, and Blood Institute (NHLBI)
Country United States of America 
Sector Public 
PI Contribution co applicants on Grant title "Blood flow affects the spatial oranizatoin of (vulnerable) plaques: new ways to modify TCFA formation"
Collaborator Contribution Co-applicant on the GrantCo-applicant on grantCo-applicant on Grant
Impact Project due to start January 2012
Start Year 2011
 
Description BHF Project Grant 
Organisation Faculty of Medicine
Department Department of Medicine
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co applicants on grant "Investigation into epigenetic basis of pulmonary hypertension: can istone deacetylase inhibitor revers the pathology?"
Collaborator Contribution Co-applicant on GrantCo-applicant on GrantCo-applicant on Grant
Impact N/A project started
Start Year 2011
 
Description BHF Project Grant 
Organisation Imperial College of Science Technology and Medicine (ICSTM)
Department Division of Investigative Science
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co applicants on grant "Investigation into epigenetic basis of pulmonary hypertension: can istone deacetylase inhibitor revers the pathology?"
Collaborator Contribution Co-applicant on GrantCo-applicant on GrantCo-applicant on Grant
Impact N/A project started
Start Year 2011
 
Description BHF Project Grant 
Organisation Medical Research Council (MRC)
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution co-applicant on grant "Genetic modifiers of cardiac iron loading in thalassaemia major"
Collaborator Contribution n/aCo applicant on Grant
Impact n/a
Start Year 2010
 
Description BHF Project Grant 
Organisation National Heart & Lung Institute (NHLI)
Department Cardiovascular Sciences, NHLI
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co applicants on grant "Investigation into epigenetic basis of pulmonary hypertension: can istone deacetylase inhibitor revers the pathology?"
Collaborator Contribution Co-applicant on GrantCo-applicant on GrantCo-applicant on Grant
Impact N/A project started
Start Year 2011
 
Description BHF Project Grant 
Organisation National Institutes of Health (NIH)
Department National Heart, Lung, and Blood Institute (NHLBI)
Country United States of America 
Sector Public 
PI Contribution co-applicant on grant "Genetic modifiers of cardiac iron loading in thalassaemia major"
Collaborator Contribution n/aCo applicant on Grant
Impact n/a
Start Year 2010
 
Description BRC Project Grant 
Organisation Division of Brain Sciences
Department Neurogenetics Group
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co applicants on Grant
Collaborator Contribution n/a
Impact n/a
Start Year 2010
 
Description EU 7th Framework Programme (FP7) 
Organisation Lund University
Country Sweden, Kingdom of 
Sector Academic/University 
PI Contribution Co-PI to Project entitled "Targets and biomarkers for antiepileptogenesis" (EPITARGET)
Collaborator Contribution PI M Kokaia.
Impact n/a
Start Year 2013
 
Description EURATRANS 
Organisation Helmholtz Association of German Research Centres
Department The Max Delbrück Center for Molecular Medicine (MDC)
Country Germany, Federal Republic of 
Sector Academic/University 
PI Contribution Co-applicant on grant
Collaborator Contribution n/a
Impact n/a
Start Year 2009
 
Description Imperial College Networks of Excellence Award 
Organisation Imperial College London (ICL)
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co-PI to project entitled " Statistical inference of large-scale biological data: An accurate view through reconfigurable computing"
Collaborator Contribution n/a
Impact n/a
Start Year 2013
 
Description MRC Project Grant 
Organisation Medical Research Council (MRC)
Department MRC Centre for Behavioural and Clinical Neuroscience Institute (BCNI)
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co-applicant
Impact n/a
Start Year 2008
 
Description NIHR Biomedical Research Centre/Imperial Innovations 
Organisation Imperial College Healthcare NHS Trust
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Hospitals 
PI Contribution PI on project entitled "SESN3 for neuronal protection"
Collaborator Contribution n/a
Impact n/a
Start Year 2012
 
Description The Academic Health Science Centre (AHSC) Grant 
Organisation Imperial College of Science Technology and Medicine (ICSTM)
Department Division of Investigative Science
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co applicants on grant "Core Research support in Genome Informatics"
Collaborator Contribution Co applicant on grantCo-applicant on grantCo-applicant on Grant
Impact n/a
Start Year 2011
 
Description The Academic Health Science Centre (AHSC) Grant 
Organisation Medical Research Council (MRC)
Department Institute of Clinical Sciences
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Public 
PI Contribution Co applicants on grant "Core Research support in Genome Informatics"
Collaborator Contribution Co applicant on grantCo-applicant on grantCo-applicant on Grant
Impact n/a
Start Year 2011
 
Description The Academic Health Science Centre (AHSC) Grant 
Organisation National Institutes of Health (NIH)
Department National Heart, Lung, and Blood Institute (NHLBI)
Country United States of America 
Sector Public 
PI Contribution Co applicants on grant "Core Research support in Genome Informatics"
Collaborator Contribution Co applicant on grantCo-applicant on grantCo-applicant on Grant
Impact n/a
Start Year 2011
 
Description UCB Pharma 
Organisation Imperial College Healthcare NHS Trust
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Hospitals 
PI Contribution Co-PI to project entitled "Network-based systems-biology approaches to identify disease modifying targets in epilepsy ("EpiNet")
Collaborator Contribution n/a
Impact n/a
Start Year 2012
 
Description Wellcome Trust Grant 
Organisation School of Public Health
Department Department of Epidemiology and Biostatistics
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co-Applicant
Collaborator Contribution n/a
Impact N/A
Start Year 2008
 
Description Wellcome Trust Project Grant 
Organisation Department of Medicine
Department Centre for Complement and Inflammation Research
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co-applicants on Grant
Collaborator Contribution n/an/a
Impact N/A
Start Year 2010
 
Description Wellcome Trust Project Grant 
Organisation Medical Research Council (MRC)
Country United Kingdom of Great Britain & Northern Ireland (UK) 
Sector Academic/University 
PI Contribution Co-applicants on Grant
Collaborator Contribution n/an/a
Impact N/A
Start Year 2010
 
Description 72nd Congress of the Italian Society of Cardiology, Rome 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Invited speaker

n/a
Year(s) Of Engagement Activity 2011
 
Description 9th International conference on pathways 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact N/A
Year(s) Of Engagement Activity 2012
 
Description American College of Rheumatology (ACR) San Diego 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact n/a
Year(s) Of Engagement Activity 2013
 
Description BHF Systems and Computational Biology, London 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Presentation of Research Results

n/a
Year(s) Of Engagement Activity 2012
 
Description CSC/MDC Joint Retreat, Berlin 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact N/A
Year(s) Of Engagement Activity 2012
 
Description Cold Spring Harbour /Wellcome Trust Meeting on Rat Genomics and Models, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Presentation of Research Results

n/a
Year(s) Of Engagement Activity 2012
 
Description EBI Meeting 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Participants in your research and patient groups
Results and Impact Presentation of Research Results

n/a
Year(s) Of Engagement Activity 2010
 
Description Euratrans Annual Meeting 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact N/A
Year(s) Of Engagement Activity 2012
 
Description GeneSys 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2009
 
Description GeneSys Meeting 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2010
 
Description Imperial College Institute for Mathematical Sciences 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2010
 
Description Imperial College Vascular Inflammation, London 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Postgraduate students
Results and Impact Presentation of Research Results

n/a
Year(s) Of Engagement Activity 2009
 
Description Institut de Recherche Cliniques de Montreal, Montreal 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Presentation of Research Results

n/a
Year(s) Of Engagement Activity 2012
 
Description Integrative Biology Workshop, Birmingham 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2010
 
Description International Mammalian Genome Conference, Japan 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2008
 
Description Late Summer Meeting, Berlin 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Presentation of Research Results

n/a
Year(s) Of Engagement Activity 2009
 
Description Le Duck Meeting, Oxford 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Presentation of Research Results

n/a
Year(s) Of Engagement Activity 2009
 
Description MDC PhD retreat, Berlin 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact n/a
Year(s) Of Engagement Activity 2010
 
Description MRC Clinical Science Centre Retreat 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Participants in your research and patient groups
Results and Impact Give talk to CSC Research Groups/students

N/A
Year(s) Of Engagement Activity 2012
 
Description Malmo Meeting 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2009
 
Description Manchester Meeting 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2009
 
Description Mykonos Meeting 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2007
 
Description NERC Microarray and Gene Expression Workshop, Liverpool 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2008
 
Description Probabilistic Modelling in Computational Biology (Vienna) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2008
 
Description Systems Biology Symposium, Imperial College London 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Presentation of Research Results

N/A
Year(s) Of Engagement Activity 2011
 
Description Systems Genetics Meeting, University of North Carolina 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Postgraduate students
Results and Impact Presentation of Research Results

n/a
Year(s) Of Engagement Activity 2011
 
Description Theo Murphy International Scientific Meeting, The Kavil royal Society Centre 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Invited speaker in session on "From bench to bedside (or breeding company)"


N/A
Year(s) Of Engagement Activity 2011
 
Description UCB Biopharma, Brussels 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Presentation of Research Results

n/a
Year(s) Of Engagement Activity 2012
 
Description YEIS 2 Barcelona Meeting 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact n/a
Year(s) Of Engagement Activity 2009